HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

reteplase

mutant form of tissue plasminogen activator used in treatment of myocardial infarct
Also Known As:
Biovail brand of reteplase; Centocor brand of reteplase; Rapilysin; Retavase; Roche brand of reteplase; 173-527-Plasminogen activator (human tissue-type), 173-L-serine-174-L-tyrosine-175-L-glutamine-
Networked: 148 relevant articles (15 outcomes, 42 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Qureshi, Adnan I: 11 articles (08/2014 - 11/2002)
2. Topol, Eric J: 6 articles (02/2010 - 11/2002)
3. Svensson, Leif: 5 articles (12/2010 - 04/2003)
4. Herlitz, Johan: 5 articles (12/2010 - 04/2003)
5. Kirmani, Jawad F: 5 articles (01/2007 - 12/2002)
6. Suri, M Fareed K: 5 articles (01/2007 - 11/2002)
7. Betriu, Amadeo: 4 articles (02/2010 - 11/2002)
8. Barnathan, Elliot S: 4 articles (02/2010 - 02/2004)
9. Savonitto, Stefano: 4 articles (10/2009 - 11/2002)
10. Lincoff, A Michael: 4 articles (10/2007 - 07/2002)

Related Diseases

1. Stroke (Strokes)
2. Myocardial Infarction
3. Arterial Occlusive Diseases (Arterial Occlusive Disease)
4. Neoplasms (Cancer)
5. Hemorrhage

Related Drugs and Biologics

1. abciximab (ReoPro)
2. Tissue Plasminogen Activator (Alteplase)
3. Streptokinase
4. Glycoproteins (Glycoprotein)
5. glucuronyl glucosamine glycan sulfate (Vessel)
6. Plasminogen Activators (Plasminogen Activator)
7. Platelet Membrane Glycoprotein IIb
8. Fibrinolytic Agents (Antithrombotic Agents)
9. tenecteplase
10. Fibrin

Related Therapies and Procedures

1. Catheters
2. Angioplasty (Angioplasty, Transluminal)
3. Stents
4. Thrombolytic Therapy
5. Limb Salvage